NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
IBS-C Questionnaire Study
IBS-C Questionnaire Study
CompletedN/A
Sponsor: AstraZeneca
Conditions: Irritable Bowel Syndrome With Constipation, Functional Constipation
Countries: China
The study is a multi-centre, observational study which enrolls 150 IBS-C patients and 150 non-IBS-C patients in China.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: Group 1 (IBS-C) * ≥18 years old * Decrease of frequency of bowel movement (\<3 time per week), change of stool consistency (stool that is hard and difficult to pass, Bristol Types 1 to 3), or other 'constipation symptoms' judged by investigators. * With abdominal symptoms such as abdominal pain, bloating, and abdominal discomfort, or other 'constipation symptoms' judged by investigators. * Result of ROME VI marked as 'IBS-C'. Group 2 (non-IBS-C) * ≥18 years old * Decrease of frequency of bowel movement (\<3 time per week), change of stool consistency (stool that is hard and difficult to pass, Bristol Types 1 to 3), or other 'constipation symptoms' judged by investigators. * With abdominal symptoms such as abdominal pain, bloating, and abdominal discomfort, or other 'constipation symptoms' judged by investigators. * Result of ROME VI marked as 'Non IBS-C'. Exclusion Criteria: * Individuals with a cognitive condition and unable to finish the questionnaire. * Individuals have an acute or chronic non-GI condition that can be associated with constipation; e.g., central nervous system cause (Parkinson's disease, spinal cord injury, and multiple sclerosis), pseudo-obstruction, colonic inertia, megacolon, megarectum, bowel obstruction, descending perineum syndrome, solitary rectal ulcer syndrome, systemic sclerosis. * Individuals who had been diagnosed with the following organic health problems likely to affect GI symptoms: * Inflammatory bowel disease (Crohn's disease or ulcerative colitis) * cancer anywhere in the GI tract or current infection of the GI tract. * Pelvic floor dysfunction. (i.e., disease that is not adequately treated or stable with therapy.) * Any history of colon surgeries. * Individuals who participate in any interventional study currently. * Not suitable for the study judged by investigators.
Locations (10)
- Beijing, China
- Guangzhou, China
- Guangzhou, China
- Nanchang, China
- Nanjing, China
- Shanghai, China
- Shenyang, China
- Wenzhou, China
- Wuhan, China
- Zhengzhou, China